focus -WSS

focus

author：comprehensive 2025-10-02 04:08:09 - browse：91

Adobe

The federal government inappropriately lowered the 2024 Medicare Advantage star ratings of SCAN Health Plan, which led to the health insurance company in California losing hundreds of millions of dollars in bonuses from the government, a judge ruled Monday.

The decision will lead to more than $250 million funneling back into SCAN, which covers 270,000 Medicare Advantage enrollees. And it opens the door for other Medicare Advantage plans to potentially recoup huge sums of taxpayer-funded bonuses — even though many independent experts believe the quality rating system is flawed and doesn’t appropriately gauge quality of care for older adults and people with disabilities.

The Centers for Medicare and Medicaid Services, the federal agency that oversees all Medicare programs, said it does not comment on litigation. In an interview, SCAN CEO Sachin Jain told STAT that if the company had not gotten its expected bonus money, it would have had to shave benefits and reduce what it pays hospitals and doctors.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Study: Black kids more likely to die after surgery than white kids

Wikipedia

entertainment

WSS

Four alarming medical procedures we’re glad history forgot

Insurer loopholes limit power of law against surprise medical bills

Clinical trials must include more disabled people

Trump cancels press conference intended to dispute Georgia election interference charges

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Majority of Americans think Trump's Ga. election interference case is serious: POLL

explore

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The pain doctors face in trying to build their families

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

The cancer drug shortage isn’t new — and neither are the solutions

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

Bright Health sells Medicare Advantage business to Molina

Covid silver lining: Unprecedented look at human immune system

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Wikipedia

ProMED sees offers of support, but its future remains unclear

Patient advocates sound warning on FDA proposal on salt intake

Cancer drug shortages' outsize impact on ovarian cancer patients

Trump's false claims about Georgia's 2020 election long debunked

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Lung cancer is America's deadliest cancer. Yet so few get screened

knowledge

Wikipedia

entertainment

leisure time